Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Shell Asset Management Co.

Shell Asset Management Co. decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 23,876 shares of the medical equipment provider’s stock after selling 1,189 shares during the quarter. Intuitive Surgical makes up 0.5% of Shell Asset Management Co.’s portfolio, making the stock its 28th biggest position. Shell Asset Management Co.’s holdings in Intuitive Surgical were worth $12,462,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of ISRG. Vanguard Group Inc. grew its stake in Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock worth $16,813,478,000 after buying an additional 360,591 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Intuitive Surgical by 3.2% in the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock valued at $4,039,200,000 after acquiring an additional 243,802 shares during the last quarter. Fisher Asset Management LLC lifted its holdings in Intuitive Surgical by 1.8% in the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after acquiring an additional 86,488 shares during the last quarter. Norges Bank acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $2,401,493,000. Finally, Invesco Ltd. raised its holdings in shares of Intuitive Surgical by 7.7% during the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider’s stock valued at $2,165,184,000 after acquiring an additional 295,025 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $560.28 on Friday. The firm has a market capitalization of $200.81 billion, a PE ratio of 87.41, a PEG ratio of 5.85 and a beta of 1.70. The company’s 50-day moving average is $503.82 and its 200-day moving average is $536.13. Intuitive Surgical, Inc. has a fifty-two week low of $393.98 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same period in the prior year, the firm earned $1.50 earnings per share. Analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the company’s stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director now directly owns 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Myriam Curet sold 2,401 shares of the firm’s stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares in the company, valued at approximately $205,093. This represents a 87.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 32,680 shares of company stock worth $16,854,345. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on ISRG. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. CICC Research began coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. Truist Financial cut their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a report on Wednesday, April 23rd. JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Raymond James raised their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.